Aurora Kinase A Market size is estimated to be USD 1.2 Billion in 2024 and is expected to reach USD 2.5 Billion by 2033 at a CAGR of 8.5% from 2026 to 2033.
The global Aurora Kinase A market was valued at approximately USD 13.03 billion in 2023 and is projected to reach USD 13.91 billion in 2024. With a compound annual growth rate (CAGR) of 6.69%, the market is expected to expand to USD 23.35 billion by 2032. This growth is driven by the increasing prevalence of cancer, advancements in targeted therapies, and rising investments in oncology research.
In 2024, North America led the market with a revenue of USD 5.4 billion, attributed to advanced healthcare infrastructure and a high incidence of cancer. Europe followed with USD 3.6 billion, driven by substantial healthcare expenditure and an aging population. The Asia Pacific region is anticipated to experience significant growth, with a projected market value of USD 7.5 billion by 2032, due to increasing healthcare spending and rising cancer rates. South America and the Middle East & Africa are also expected to contribute to market expansion as awareness and access to cancer treatments improve.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=854128&utm_source=Pulse_G_April&utm_medium=226
Â
AbbVie Inc
Amgen Inc
Astex Pharmaceuticals
Inc
CASI Pharmaceuticals Inc
Merck & Co.
Inc
Millennium Pharmaceuticals
Inc
Sanofi
Sareum Holdings Plc
Sigma-Tau S.p.A.
Taiho Pharmaceutical Co.
Ltd.
Vertex Pharmaceuticals Incrporated
Vichem Chemie Research Ltd.
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=854128&utm_source=Pulse_G_April&utm_medium=226
Growing demand for below applications around the world has had a direct impact on the growth of the Global Aurora Kinase A Market
Small Molecule Inhibitors
Monoclonal Antibodies
Combination Therapies
Oncology
Neurological Disorders
Cardiovascular Diseases
Pharmaceutical Companies
Research Institutions
Hospitals and Clinics
Direct Sales
Online pharmacies
Hospital Pharmacies
Aromatic Compounds
Aliphatic Compounds
Heterocyclic Compounds
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/aurora-kinase-a-market/
1. Introduction of the Global Aurora Kinase A Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Aurora Kinase A Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Aurora Kinase A Market, By Type
6. Global Aurora Kinase A Market, By Application
7. Global Aurora Kinase A Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global Aurora Kinase A Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/